Latest filing published 14 Apr 2025 for Nutex Health, Inc..
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joshua DeTillio: trading record in brief
This profile gathers the share dealings of Joshua DeTillio in Nutex Health, Inc. Between 15 November 2023 and 4 April 2025, the trades on record add up to 6 filings.
No open-market sale appears; the market trades are 4 purchases worth €71k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant and 1 option exercise.
The median purchase comes to €15k. 1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The latest filing, published on 14 April 2025, reports a share grant of €30k in Nutex Health, Inc. The most recent open-market purchase was published on 21 August 2024, 810 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Joshua DeTillio
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,125 shares0Common StockSEC:0001486189-25-000015:0
- 1,300 shares@ US$17.8533.6% of flowCommon StockSEC:0001486189-24-000042:0Canonical exit: 17 Nov 2024 (T+90)
- 20,000 shares@ US$0.5416.0% of flowCommon StockSEC:0001486189-24-000028:0Canonical exit: 10 Sept 2024 (T+90)
- 140,000 shares@ US$0.244150.4% of flowCommon StockSEC:0001486189-23-000041:0Canonical exit: 13 Feb 2024 (T+90)
4 of 4 declarations